Cargando…

Validation of the EuroSCORE II in a Greek Cardiac Surgical Population: A Prospective Study

OBJECTIVE: The objective of this study was to examine the validity of EuroSCORE II in the Greek population. METHODS: A prospective single-center study was performed during November 1, 2013 and November 5, 2016; 621 patients undergoing cardiac surgery were enrolled. The EuroSCORE II values and the ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Stavridis, G., Panaretos, D., Kadda, O., Panagiotakos, D. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688389/
https://www.ncbi.nlm.nih.gov/pubmed/29204219
http://dx.doi.org/10.2174/1874192401711010094
_version_ 1783279152710811648
author Stavridis, G.
Panaretos, D.
Kadda, O.
Panagiotakos, D. B.
author_facet Stavridis, G.
Panaretos, D.
Kadda, O.
Panagiotakos, D. B.
author_sort Stavridis, G.
collection PubMed
description OBJECTIVE: The objective of this study was to examine the validity of EuroSCORE II in the Greek population. METHODS: A prospective single-center study was performed during November 1, 2013 and November 5, 2016; 621 patients undergoing cardiac surgery were enrolled. The EuroSCORE II values and the actual mortality of the patients were recorded in a special database. Calibration of the model was evaluated with the Hosmer-Lemeshow goodness-of-fit test, and discrimination with the areas under the receiver operating characteristic (ROC) curve. RESULTS: The observed in-hospital mortality rate was 3% (i.e. 18/621 patients). The median EuroSCORE II value was 1.3% (1(st) quartile: 0.86%, 3(rd) quartile: 2.46%), which indicates a low in-hospital mortality. Area under the ROC curve for EuroSCORE II was 0.85 (95% CI: 0.75-0.94), suggesting very good correct classification of the patients. CONCLUSION: The findings of the present work suggest that EuroSCORE II is a very good predictor of in-hospital mortality after cardiac surgery, in our population and, therefore can safely be used for quality assurance and risk assessment.
format Online
Article
Text
id pubmed-5688389
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-56883892017-12-04 Validation of the EuroSCORE II in a Greek Cardiac Surgical Population: A Prospective Study Stavridis, G. Panaretos, D. Kadda, O. Panagiotakos, D. B. Open Cardiovasc Med J Article OBJECTIVE: The objective of this study was to examine the validity of EuroSCORE II in the Greek population. METHODS: A prospective single-center study was performed during November 1, 2013 and November 5, 2016; 621 patients undergoing cardiac surgery were enrolled. The EuroSCORE II values and the actual mortality of the patients were recorded in a special database. Calibration of the model was evaluated with the Hosmer-Lemeshow goodness-of-fit test, and discrimination with the areas under the receiver operating characteristic (ROC) curve. RESULTS: The observed in-hospital mortality rate was 3% (i.e. 18/621 patients). The median EuroSCORE II value was 1.3% (1(st) quartile: 0.86%, 3(rd) quartile: 2.46%), which indicates a low in-hospital mortality. Area under the ROC curve for EuroSCORE II was 0.85 (95% CI: 0.75-0.94), suggesting very good correct classification of the patients. CONCLUSION: The findings of the present work suggest that EuroSCORE II is a very good predictor of in-hospital mortality after cardiac surgery, in our population and, therefore can safely be used for quality assurance and risk assessment. Bentham Open 2017-09-30 /pmc/articles/PMC5688389/ /pubmed/29204219 http://dx.doi.org/10.2174/1874192401711010094 Text en © 2017 Stavridis et al. https://creativecommons.org/licenses/by/4.0/legalcode This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Article
Stavridis, G.
Panaretos, D.
Kadda, O.
Panagiotakos, D. B.
Validation of the EuroSCORE II in a Greek Cardiac Surgical Population: A Prospective Study
title Validation of the EuroSCORE II in a Greek Cardiac Surgical Population: A Prospective Study
title_full Validation of the EuroSCORE II in a Greek Cardiac Surgical Population: A Prospective Study
title_fullStr Validation of the EuroSCORE II in a Greek Cardiac Surgical Population: A Prospective Study
title_full_unstemmed Validation of the EuroSCORE II in a Greek Cardiac Surgical Population: A Prospective Study
title_short Validation of the EuroSCORE II in a Greek Cardiac Surgical Population: A Prospective Study
title_sort validation of the euroscore ii in a greek cardiac surgical population: a prospective study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688389/
https://www.ncbi.nlm.nih.gov/pubmed/29204219
http://dx.doi.org/10.2174/1874192401711010094
work_keys_str_mv AT stavridisg validationoftheeuroscoreiiinagreekcardiacsurgicalpopulationaprospectivestudy
AT panaretosd validationoftheeuroscoreiiinagreekcardiacsurgicalpopulationaprospectivestudy
AT kaddao validationoftheeuroscoreiiinagreekcardiacsurgicalpopulationaprospectivestudy
AT panagiotakosdb validationoftheeuroscoreiiinagreekcardiacsurgicalpopulationaprospectivestudy